Case: 73 yr-old male with DM and HTN. No hx of CAD or Afib. On ACEi, Thiazide, and Bb. BP <120/80. HR < 60 bpm. A1c = 7.1%. No ADRs. Should Bb be deprescribed?

  • No! Smooth sailing. (9%, 14 Votes)
  • No! But re-assess annually (24%, 37 Votes)
  • Yes! But resume if HR > 80 (16%, 25 Votes)
  • Yes! But start CCB if BP >130/80 (51%, 80 Votes)

Total Voters: 156

Start Date: July 11, 2021 @ 10:52 AM
End Date: No Expiry

When it comes to weight loss, GLP-1 receptor agonists, like semaglutide, should be:

  • a last ditch option for those with multiple co-morbidities. (3%, 3 Votes)
  • a 2nd line option; used only after lifestyle changes have been implemented. (36%, 35 Votes)
  • considered as an adjunct to lifestyle to anyone with a BMI > 30 (54%, 52 Votes)
  • offered to anyone who needs to kick-start weight loss (7%, 7 Votes)

Total Voters: 97

Start Date: June 2, 2021 @ 3:44 PM
End Date: July 11, 2021 @ 11:00 AM

Mindfulness-Base Stress Reduction (MBSR) programs (8+week meditation and yoga training) ...

  • might make you "feel good" but don't have evidence-based benefits. (5%, 2 Votes)
  • are likely effective as an adjunctive treatment for stress and anxiety. (48%, 19 Votes)
  • have a wide range of proven benefits and should be covered by payers. (35%, 14 Votes)
  • should be routinely offered and as common as ordering a screening lipid panel. (12%, 5 Votes)

Total Voters: 40

Start Date: March 24, 2021 @ 9:00 AM
End Date: June 2, 2021 @ 3:53 PM

 Page 11 of 13  « First ... «  4  5  6  7  8  9  10  11  12  13  »